// App-Quantinova.ai

1095 : S100A4 is post-transcriptionally inhibited by miR-505-5p and miR-520c-3p in colorectal cancer

Researchers

Presenter

  • Giridhar Mudduluru

Principal Investigators

  • Katharina Ilm

  • Steffen Fuchs

  • Ulrike Stein

Medical Centers

  • Experimental and Clinical Research Center, Charite Universitatsmedizin Berlin and Max-Delbruck-Center for Molecular Medicine, Berlin, Germany

  • Experimental and Clinical Research Center, Charite Universitatsmedizin Berlin and Max-Delbruck-Center for Molecular Medicine, Berlin, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved